Integrating human and artificial intelligence for robust postmarketing safety surveillance systems: reflections from the FDA Sentinel Innovation Center

Clicks: 36
ID: 320954
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #41 of 76 articles by views in Journal of the American Medical Informatics Association : JAMIA

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Objectives To describe considerations for integration of human and artificial intelligence for creating a postmarketing surveillance system capable of timely and reliably identifying causal effects of medications on safety endpoints. Materials and Methods The FDA has prioritized more extensive Electronic Health Records (EHR) integration along with generative artificial intelligence and machine learning (Gen AI/ML) into the national active surveillance program for medical products—the Sentinel Initiative. Based on our experience of leading these efforts, we provide perspectives on the opportunities and challenges of Gen AI/ML integration into Sentinel. Results Using specific examples, we outline the role of Gen AI and ML in a causal inference framework for scalable information extraction, assessment of fitness-for-purpose of data sources, diagnosing residual confounding, and enhancing confounding adjustment. Critically, we outline steps and checkpoints along the way where human involvement remains indispensable. Discussion and conclusion In public health applications where stakes are high, use of Gen AI/ML needs to be carefully considered with appropriate guardrails ensuring human expert involvement.
Reference Key
openalex_W7168289862 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rishi J Desai, Robert Ball, Gerald Dal Pan, Sebastian Schneeweiss
Journal Journal of the American Medical Informatics Association : JAMIA
Year 2026
DOI
10.1093/jamia/ocag121
URL
https://doi.org/10.1093/jamia/ocag121
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.